Not all chronic pain is the same. Learn how to identify the type you have—and discover which treatments, including ...

Although the two-dose shingles vaccine may force you to lay low for a day or two after getting the shot, it’s over 90% ...

Neuropathic pain, a complex and often debilitating condition, presents a significant challenge to both patients and ...

Herpes zoster (shingles) vaccine may reduce dementia risk by curbing neuroinflammation and viral reactivation—adding brain ...

Dr. Miller says cleaning your rash once a day is plenty. If you choose to do so in the shower, use lukewarm water; high heat ...

The research, led by Stanford University’s School of Medicine, examined the health records of over 280,000 older adults in ...

The recombinant zoster vaccine is protective against herpes zoster and postherpetic neuralgia among patients aged at least 50 years with rheumatoid arthritis. The recombinant zoster vaccine (RZV) ...

A significant number of patients, up to 20 per cent, experience lingering nerve pain, known as postherpetic neuralgia, for months or even years after the rash disappears. It's not clear exactly ...

A study published in Nature found that vaccinating against shingles lowered the risk of developing dementia by 20 per cent over a seven-year period. The research, led by Dr. Pascal Geldsetzer of ...

Aveva Drug Delivery Systems has received permission from the Food and Drug Administration for its generic lidocaine 1.8% ...

The color bar indicates the maximum and minimum SDM-Z values. HCs, healthy controls; PHN, postherpetic neuralgia, SDM, seed-based mapping. The results of Egger’s test for the MTG.R (Bias 0.21, Z 0.12, ...